Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-naïve Men?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Knowledge of significant prostate (sPCa) locations being missed with magnetic resonance (MR)- and transrectal ultrasound (TRUS)-guided biopsy (Bx) may help to improve these techniques.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur. Urol.

Title: European urology

Publisher: Elsevier BV

ISSN (Electronic): 1873-7560

ISSN (Print): 0302-2838

Publication date (Electronic): Jun 2017

Volume: 71

Issue: 6

Affiliations

[1 ] Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: martijn.schouten@radboudumc.nl.

[2 ] Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

[3 ] Department of Urology, The Wesley Hospital, Brisbane, Australia.

Article

Publisher Item ID: S0302-2838(16)30903-4

DOI: 10.1016/j.eururo.2016.12.006

PubMed ID: 28063613

SO-VID: e58f6a23-d880-4b0b-9021-7dd5592da75e

History

Keywords: Biopsy,Cancer,Location,MRI,Prostate

Data availability:

Keywords: Biopsy, Cancer, Location, MRI, Prostate

Comments

Comment on this article

scite_

Cited by 37

See all cited by